Best Marijuana Stocks: Cannabis Science (CBIS)
11/20 Stock Price: 3 cents
Market Cap: $24 million
YTD Performance: -34%
Cannabis Science (CBIS) is probably the most “medical” of all medical marijuana stocks. It’s led by Dr. Robert Melamede, a leading scientist in the field of cannabinoid research.
As such, Cannabis Science looks more like a biotech or pharma company than the rest of these marijuana stocks, since it seeks to develop cannabinoid-based products for approval by the Food and Drug Administration.
So far, that hasn’t been a very good bet for investors. Shares of CBIS stock are off 34% for the year-to-date, and — again — like all medical marijuana stocks, they are volatile. Cannabis Science stock was actually up about 90% back in February.
CBIS had no revenue in the most recent quarter and a loss of $928,000. As a result, Cannabis Science is looking for additional capital to stay afloat. Still, CBIS stock makes this list because it’s also more heavily traded than some smaller marijuana stocks.